Witnessing the stock’s movement on the chart, on November 08, 2021, Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) set off with pace as it heaved 2.33% to $13.20. During the day, the stock rose to $13.21 and sunk to $12.88 before settling in for the price of $12.90 at the close. Taking a more long-term approach, IRWD posted a 52-week range of $8.78-$14.27.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 21.10%. Meanwhile, its Annual Earning per share during the time was 21.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 74.90%. This publicly-traded company’s shares outstanding now amounts to $161.95 million, simultaneously with a float of $160.56 million. The organization now has a market capitalization sitting at $2.10 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.00, while the 200-day Moving Average is $11.91.
Let’s gauge the efficiency of the firm, which has a total of 232 employees. It has generated 1,678,978 per worker during the last fiscal year. Meanwhile, its income per employee was 457,655. The stock had 3.25 Receivables turnover and 0.81 Total Asset turnover. For the Profitability, stocks gross margin was +98.28, operating margin was +40.65 and Pretax Margin of +27.95.
Ironwood Pharmaceuticals Inc. (IRWD) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. According to the most recent insider trade that took place on Aug 16, this organization’s Principal Accounting Officer sold 567 shares at the rate of 13.48, making the entire transaction reach 7,643 in total value, affecting insider ownership by 62,675. Preceding that transaction, on Aug 16, Company’s SVP, Chief Operating Officer sold 680 for 13.48, making the whole transaction’s value amount to 9,166. This particular insider is now the holder of 361,858 in total.
Ironwood Pharmaceuticals Inc. (IRWD) Earnings and Revenue Records
As on 6/29/2021, Multinational firm has announced its last quarter scores, in which it reported $0.34 earnings per share (EPS) for the period topping the consensus outlook (set at $0.23) by $0.11. This company achieved a net margin of +27.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
Ironwood Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 74.90% and is forecasted to reach 1.44 in the upcoming year.
Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) Trading Performance Indicators
Let’s observe the current performance indicators for Ironwood Pharmaceuticals Inc. (IRWD). The Stock has managed to achieve an average true range (ATR) of 0.39. Alongside those numbers, its PE Ratio stands at $4.23, and its Beta score is 1.22. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.08.
In the same vein, IRWD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 3.12, a figure that is expected to reach 0.33 in the next quarter, and analysts are predicting that it will be 1.44 at the market close of one year from today.
Technical Analysis of Ironwood Pharmaceuticals Inc. (IRWD)
Going through the that latest performance of [Ironwood Pharmaceuticals Inc., IRWD]. Its last 5-days volume of 2.37 million indicated improvement to the volume of 1.94 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 74.18% While, its Average True Range was 0.39.
Raw Stochastic average of Ironwood Pharmaceuticals Inc. (IRWD) in the period of the previous 100 days is set at 63.10%, which indicates a major fall in contrast to 74.48% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 28.40% that was higher than 25.67% volatility it exhibited in the past 100-days period.